journal article·2025-05Open access

Nature Knows Best: Extracellular Matrix‐Gelatin Hydrogel Masking Bioauthentic Bone Scaffold Locking Blood Clot to Induce M2 Macrophage‐Mediated Bone Regeneration via Activating an Endocytosis‐Macroautophagy‐Inflammation Axis

Jieyun Xu, Xiaoran Yu, Hongcheng Chen, Junlong Xue, Zhuohong Gong, Zhengjie Shan, Shijie Chen, Yuanlong Guo, Xiaomeng Gao, Linjun Zhang, Yin Xiao, Feilong Deng, Zetao Chen

Small Structures· Volume 6· Issue 5

Abstract

Individualized biological hydroxyapatite (BHA) scaffolds are essential for repairing critical craniomaxillofacial bone defects. Additive manufacturing relies on synthetic hydroxyapatite and biomimetic structures, making the resulting scaffolds inferior to natural bone. A subtractive manufacturing solution is proposed to cut natural bone blocks and then sinter them into BHA scaffolds. However, BHA scaffolds with fragile mechanical performance, fail to maintain scaffold integrity, due to microcracks generated by loss of organics from extracellular matrix (ECM). To preserve natural structure and enhance mechanical properties, ECM‐gelatin hydrogel (ECM‐Gel) is utilized as a micron‐level coating to smooth surface microcracks like a facial mask. ECM‐Gel shows potential in regulating blood clot fibrin network which may induce a favorable macrophage‐mediated bone regeneration. Therefore, a gelatin hydrogel‐masked BHA (G‐BHA) scaffold system is developed using crosslinker genipin (2 and 8 mM). ECM‐Gel formed a “hybrid layer”, smoothing the micron‐level microcracks and enhancing mechanical properties of BHA; it activated platelets to lock blood clot with dense fibrin network, inducing M2 macrophage via a potential endocytosis‐macroautophagy‐inflammation axis for bone regeneration. In vivo experiments confirmed G‐BHA scaffolds promoted ectopic and in situ bone regeneration. Therefore, ECM‐gel‐masking demonstrates great potential in developing individualized bioauthentic bone scaffolds with favorable blood clot and macrophage‐mediated bone regeneration.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Periodontal Regeneration and Treatments · Bone Tissue Engineering Materials · Connective tissue disorders research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Hospital of Stomatology Sun Yat‐sen University and Guangdong Provincial Key Laboratory of Stomatology Guangzhou 510055 China

School of Medicine and Dentistry & Institute for Biomedicine and Glycomics Griffith University Queensland 4222 Australia

Funding

Basic and Applied Basic Research Foundation of Guangdong Province · National Natural Science Foundation of China

References (56)

Show source-provided references
1. 10.3390/ijms2317972110.3390/ijms23179721 ↗
2. 10.1002/adfm.20200696710.1002/adfm.202006967 ↗
3. 10.1002/adfm.20210137210.1002/adfm.202101372 ↗
4. 10.1002/advs.20210089410.1002/advs.202100894 ↗
5. 10.1016/j.oceram.2021.10012210.1016/j.oceram.2021.100122 ↗
6. 10.1016/j.biomaterials.2024.12256610.1016/j.biomaterials.2024.122566 ↗
7. 10.1016/j.ijbiomac.2023.12515010.1016/j.ijbiomac.2023.125150 ↗
8. 10.1021/acsbiomaterials.2c0137710.1021/acsbiomaterials.2c01377 ↗
9. 10.1038/s41413-022-00223-y10.1038/s41413-022-00223-y ↗
10. 10.26599/NBE.2024.929005110.26599/NBE.2024.9290051 ↗
11. 10.1080/0192623060093985610.1080/01926230600939856 ↗
12. 10.1038/s41598-018-20006-y10.1038/s41598-018-20006-y ↗
13. 10.7150/thno.1661410.7150/thno.16614 ↗
14. 10.1038/s41598-024-60701-710.1038/s41598-024-60701-7 ↗
15. 10.1002/adfm.20231246510.1002/adfm.202312465 ↗
16. 10.1182/blood-2002-12-388210.1182/blood-2002-12-3882 ↗
17. 10.1016/j.rpth.2022.10002310.1016/j.rpth.2022.100023 ↗
18. 10.1182/blood-2015-05-64426010.1182/blood-2015-05-644260 ↗
19. 10.34133/research.022510.34133/research.0225 ↗
20. 10.1002/adhm.20210091810.1002/adhm.202100918 ↗
21. 10.1186/s13054-022-03940-210.1186/s13054-022-03940-2 ↗
22. 10.1080/10255842.2020.171347110.1080/10255842.2020.1713471 ↗
23. 10.1038/s41536-023-00330-210.1038/s41536-023-00330-2 ↗
24. 10.1016/j.actbio.2023.01.05810.1016/j.actbio.2023.01.058 ↗
25. 10.1177/204173142097486110.1177/2041731420974861 ↗
26. 10.1038/s41598-019-47059-x10.1038/s41598-019-47059-x ↗
27. 10.1016/j.foodhyd.2023.10861610.1016/j.foodhyd.2023.108616 ↗
28. 10.1039/D0BM01403F10.1039/D0BM01403F ↗
29. 10.1016/j.foodres.2022.11124010.1016/j.foodres.2022.111240 ↗
30. 10.3390/ma307386710.3390/ma3073867 ↗
31. 10.3390/bioengineering910051310.3390/bioengineering9100513 ↗
32. 10.1039/D2TB02825E10.1039/D2TB02825E ↗
33. 10.1038/s41598-023-42472-910.1038/s41598-023-42472-9 ↗
34. 10.1088/1758-5082/6/3/03501310.1088/1758-5082/6/3/035013 ↗
35. 10.1016/j.mattod.2022.02.01010.1016/j.mattod.2022.02.010 ↗
36. 10.1016/j.blre.2020.10073310.1016/j.blre.2020.100733 ↗
37. 10.1002/advs.20210360810.1002/advs.202103608 ↗
38. 10.1111/jth.1437010.1111/jth.14370 ↗
39. 10.1016/j.bioactmat.2023.04.00810.1016/j.bioactmat.2023.04.008 ↗
40. 10.1016/j.bioactmat.2022.05.01310.1016/j.bioactmat.2022.05.013 ↗
41. 10.1007/978-3-319-49674-0_1310.1007/978-3-319-49674-0_13 ↗
42. Kornilova E. S. · Biochemistry · 2014 · 79 · 865
43. 10.1126/sciadv.abn170210.1126/sciadv.abn1702 ↗
44. 10.1016/j.molcel.2020.11.02010.1016/j.molcel.2020.11.020 ↗
45. 10.1016/j.celrep.2023.11270810.1016/j.celrep.2023.112708 ↗
46. 10.1038/nri.2016.10010.1038/nri.2016.100 ↗
47. 10.1016/j.mattod.2015.11.00410.1016/j.mattod.2015.11.004 ↗
48. 10.2119/molmed.2010.0014610.2119/molmed.2010.00146 ↗
49. 10.4161/auto.2692710.4161/auto.26927 ↗
50. 10.1016/j.rpth.2023.10008110.1016/j.rpth.2023.100081 ↗
51. 10.1182/bloodadvances.202100481610.1182/bloodadvances.2021004816 ↗
52. 10.1172/JCI15301410.1172/JCI153014 ↗
53. 10.1016/j.immuni.2021.10.00710.1016/j.immuni.2021.10.007 ↗
54. 10.1038/s41598-023-47694-510.1038/s41598-023-47694-5 ↗
55. 10.1089/scd.2011.051710.1089/scd.2011.0517 ↗
56. 10.1002/btm2.1011010.1002/btm2.10110 ↗